NABOTA

onabotulinumtoxinA · Daewoong Pharmaceutical Co. LTD.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NABOTA, covering 2019-06-26 to 2019-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm [Phase 2, Phase 3]